Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03304314 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multifocal Chromatic Pupilloperimetry in Patients With Pseudotumor Cerebri and Healthy Subjects.

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 31, 2025 to Dec 31, 2027v6
  2. Primary and study completion dates: Dec 31, 2024 to Dec 31, 2025v5
  3. Primary and study completion dates: Dec 31, 2021 to Dec 31, 2024v4
  4. Primary completion date: Oct 31, 2020 to Dec 31, 2021
    • Study completion date: Oct 31, 2021 to Dec 31, 2021
    v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Study completion date: Oct 31, 2020 to Oct 31, 2021
    • Start date changed from estimate of Oct 15, 2017 to Nov 3, 2017
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
PTC(Pseudotumor cerebri) patients may develop increased Intracranial pressure (ICP) that can produces increased pressure around the distal optic nerve,which is likely followed by venule compression, ischemia, and loss of visual function.Vision loss in PTC is most commonly characterized by standard automated perimetry to measure peripheral visual field sensitivity. Pupillometry is a promising approach for functional assessment in PTC because it is noninvasive, objective, performed quickly with minimal patient cooperation needed. The feasibility of using chromatic multifocal pupillometry for assesment of PTC will be examined.
Trial Details
NCT Number NCT03304314
Lead Sponsor Sheba Medical Center
Conditions
(from sponsor)		 Pseudotumor Cerebri
Related terms Intracranial Hypertension, Pseudotumor Cerebri
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov